InChI
1S/Bi
SMILES string
[Bi]
InChI key
JCXGWMGPZLAOME-UHFFFAOYSA-N
vapor pressure
<0.1 mmHg ( 20 °C)
assay
≥99.97%
form
foil
manufacturer/tradename
Goodfellow 096-552-63
resistivity
129 μΩ-cm, 20°C
bp
1560 °C (lit.)
mp
271 °C (lit.)
density
9.8 g/mL at 25 °C (lit.)
正在寻找类似产品? 访问 产品对比指南
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
法规信息
新产品
此项目有
Hong Lu et al.
European journal of gastroenterology & hepatology, 25(10), 1134-1140 (2013-06-20)
Antimicrobial resistance has continued to undermine many popular anti-Helicobacter pylori therapies. Antibiotic resistance to commonly used anti-H. pylori drugs in China has increased markedly, making China an ideal site to identify regimens that remain effective despite widespread antimicrobial resistance. Bismuth
Ruiguang Ge et al.
Metallomics : integrated biometal science, 4(3), 239-243 (2012-02-24)
Helicobacter pylori causes various gastric diseases, such as gastritis, peptic ulcerations and gastric cancer. Bismuth-based triple or quadruple therapies have been commonly recommended for the treatment of H. pylori infections. Up to now, the molecular mechanisms by which bismuth inhibits
Syntheses of biodegradable and biocompatible polymers by means of bismuth catalysts.
Hans R Kricheldorf
Chemical reviews, 109(11), 5579-5594 (2009-09-26)
Bismuth in medicine.
Hongzhe Sun et al.
Metal ions in biological systems, 41, 333-378 (2004-06-23)
Jorge A R Salvador et al.
Future medicinal chemistry, 4(11), 1495-1523 (2012-08-04)
In recent years, the chemical potential of bismuth and bismuth compounds has been actively exploited. Bismuth salts are known for their low toxicity, making them potential valuable reagents for large-scale synthesis, which becomes more obvious when dealing with products such
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持